NPI: 1679549273 · NEW LONDON, CT 06320 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/24/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/24/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 33,521 | $632K |
| 2019 | 42,414 | $398K |
| 2020 | 35,691 | $317K |
| 2021 | 29,607 | $383K |
| 2022 | 22,900 | $167K |
| 2023 | 9,848 | $68K |
| 2024 | 4,451 | $17K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 62,273 | 4,342 | $586K |
| 83970 | 3,351 | 2,719 | $449K | |
| 82728 | 2,613 | 2,281 | $308K | |
| 83550 | 2,375 | 2,058 | $174K | |
| 83540 | 2,631 | 2,292 | $139K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 53,664 | 2,833 | $123K |
| J1270 | Injection, doxercalciferol, 1 mcg | 23,904 | 1,940 | $85K |
| 85045 | 3,504 | 3,085 | $27K | |
| 85041 | 3,702 | 3,227 | $23K | |
| A4657 | Syringe, with or without needle, each | 3,760 | 3,315 | $18K |
| 85048 | 3,703 | 3,228 | $16K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 931 | 609 | $12K |
| J1756 | Injection, iron sucrose, 1 mg | 10,134 | 2,734 | $11K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 739 | 317 | $7K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 507 | 291 | $2K |
| G0008 | Administration of influenza virus vaccine | 146 | 136 | $132.25 |
| 90674 | 123 | 113 | $0.00 | |
| 90662 | 29 | 28 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 343 | 95 | $0.00 |